Charles P. Carey - 31 Dec 2023 Form 5 Insider Report for CME GROUP INC. (CME)

Role
Director
Signature
By: Jenelle Chalmers For: Charles P. Carey
Issuer symbol
CME
Transactions as of
31 Dec 2023
Net transactions value
-$860
Form type
5
Filing time
15 Mar 2024, 16:20:12 UTC
Previous filing
28 Jun 2023
Next filing
14 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CME Class B Common Stock, Series B-2 Sale $212 -1 -100% $211.93 0 06 Oct 2023 by Partnership F1
transaction CME Class B Common Stock, Series B-1 Sale $216 -1 -100% $215.76 0 09 Oct 2023 by Partnership F2
transaction CME Class B Common Stock, Series B-3 Sale $216 -1 -100% $215.76 0 09 Oct 2023 by Partnership F2
transaction CME Class B Common Stock, Series B-4 Sale $216 -1 -100% $216.09 0 10 Oct 2023 by Partnership F3
holding CME Common Stock Class A 10,163 31 Dec 2023 by Trust
holding CME Common Stock Class A 0 31 Dec 2023 by Partnership
holding CME Common Stock Class A 185 31 Dec 2023 By Firm
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 5 is being filed to reflect an update to Mr. Carey's ownership of Class B shares that were previously reported as being indirectly owned by Mr. Carey in connection with his ownership of HC Technologies. Subsequent to the sale of HC Technologies' assets, one Class B-2 share was sold on October 6, 2023. The Class B common stock of CME Group Inc. is not listed on a national securities exchange or traded in an organized over-the-counter market. Each class of the Class B common stock is associated with a membership in a specific division of the exchange. We assume that because the Class B shares have the same equitable interest in our earnings and the same dividend payments as our Class A shares, that if reported separately from the associated trading rights, they would have the same market price as our Class A common stock. The closing price for our Class A common stock on October 6, 2023 was $211.93.
F2 This Form 5 is being filed to reflect an update to Mr. Carey's ownership of Class B shares that were previously reported as being indirectly owned by Mr. Carey in connection with his ownership of HC Technologies. Subsequent to the sale of HC Technologies' assets, one Class B-1 share and one Class B-3 share were sold on October 9, 2023. The Class B common stock of CME Group Inc. is not listed on a national securities exchange or traded in an organized over-the-counter market. Each class of the Class B common stock is associated with a membership in a specific division of the exchange. We assume that because the Class B shares have the same equitable interest in our earnings and the same dividend payments as our Class A shares, that if reported separately from the associated trading rights, they would have the same market price as our Class A common stock. The closing price for our Class A common stock on October 9, 2023 was $215.76
F3 This Form 5 is being filed to reflect an update to Mr. Carey's ownership of Class B shares that were previously reported as being indirectly owned by Mr. Carey in connection with his ownership of HC Technologies. Subsequent to the sale of HC Technologies' assets, one Class B-4 share was sold on October 10, 2023. The Class B common stock of CME Group Inc. is not listed on a national securities exchange or traded in an organized over-the-counter market. Each class of the Class B common stock is associated with a membership in a specific division of the exchange. We assume that because the Class B shares have the same equitable interest in our earnings and the same dividend payments as our Class A shares, that if reported separately from the associated trading rights, they would have the same market price as our Class A common stock. The closing price for our Class A common stock on October 10, 2023 was $216.09.